250 related articles for article (PubMed ID: 4933915)
1. Immunity to malignant disease in man.
Fairley GH
Sci Basis Med Annu Rev; 1971; ():17-38. PubMed ID: 4933915
[No Abstract] [Full Text] [Related]
2. Immunity in malignant disease.
Fairley GH
Trans Med Soc Lond; 1968; 84():96-109. PubMed ID: 5708160
[No Abstract] [Full Text] [Related]
3. Immunology and malignant disease.
Klein E; Cochran AJ
Haematologia (Budap); 1971; 5(3):179-203. PubMed ID: 4108507
[No Abstract] [Full Text] [Related]
4. Immunity to malignant disease in man.
Fairley GH
Br Med J; 1969 May; 2(5655):467-73. PubMed ID: 5771576
[No Abstract] [Full Text] [Related]
5. [Immunity reactions and the pharmacotherapy of malignant neoplasms (allergy and cancer)].
Ado VA
Fiziol Zh; 1976; 22(2):265-71. PubMed ID: 791690
[No Abstract] [Full Text] [Related]
6. The suppressor-cell network in cancer (second of two parts).
Broder S; Waldmann TA
N Engl J Med; 1978 Dec; 299(24):1335-41. PubMed ID: 362202
[No Abstract] [Full Text] [Related]
7. [Factors of bodily resistance and metastasis].
Maĭskiĭ IN; Lomakin MS
Usp Sovrem Biol; 1976; 82(4):63-76. PubMed ID: 790816
[No Abstract] [Full Text] [Related]
8. [Cancer and immunity].
Nagel GA; Geiger C
Schweiz Med Wochenschr; 1971 Nov; 101(45):1605-20. PubMed ID: 4947152
[No Abstract] [Full Text] [Related]
9. [Cancer and the lymphatic system].
Grekh IF
Vopr Onkol; 1971 Sep; 17(10):101-10. PubMed ID: 4947716
[No Abstract] [Full Text] [Related]
10. Immune stimulation-inhibition of experimental cancer metastasis.
Fidler IJ
Cancer Res; 1974 Mar; 34(3):491-8. PubMed ID: 4812256
[No Abstract] [Full Text] [Related]
11. Immunotherapy of leukemia: the use of different classes of immune lymphocytes.
Alexander P
Cancer Res; 1967 Dec; 27(12):2521-6. PubMed ID: 6082294
[No Abstract] [Full Text] [Related]
12. Tumour-associated antigens and tumour-host interactions.
Baldwin RW
Proc R Soc Med; 1971 Oct; 64(10):1039-42. PubMed ID: 4335921
[No Abstract] [Full Text] [Related]
13. Some immunologically based reactions that can cause the regression of large tumor masses.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():105-8. PubMed ID: 799755
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of human leukemia.
Baker MA; Taub RN
Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
[No Abstract] [Full Text] [Related]
15. Effect of whole and lysed sensitized lymphocytes on murine tumor growth and host survival.
Greco RS; Schmidt DR; Storer EH
Surg Forum; 1973; 24():109-11. PubMed ID: 4808028
[No Abstract] [Full Text] [Related]
16. [Immunology and immunotherapy of malignant neoplasms and blood diseases].
Papaleo G; Zito GA; Giordano G
Recenti Prog Med; 1978 Mar; 64(3):310-53. PubMed ID: 351752
[No Abstract] [Full Text] [Related]
17. Immunologic aspects of cancer.
Sophocles AM; Nadler SH
Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
[No Abstract] [Full Text] [Related]
18. [Immunotherapy of cancer].
Lascano FD; Mazzei JA; Estevez ME
Prensa Med Argent; 1971 Mar; 58(2):75-91. PubMed ID: 4103879
[No Abstract] [Full Text] [Related]
19. [Experimental induction of the delayed reaction as immunologica indicator (in dermatoses, tumors, immunosuppression)].
Remy W; Stüttgen G
Allerg Immunol (Leipz); 1972; 18(2):97-104. PubMed ID: 4266967
[No Abstract] [Full Text] [Related]
20. [Problems of tumor immunity and the possibility of immunotherapy in tumor].
Shimoyama M
Nihon Rinsho; 1971; 29(6):1515-29. PubMed ID: 4933610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
